On Sunday evening, CBS's 60 Minutes aired a segment featuring "The Five Eyes" and the critical issue of state-sponsored intellectual property ("IP") and trade secret theft.

Against the backdrop of the San Francisco JPMorgan Healthcare Conference, Axinn, Cornerstone, and Concurrences hosted a reception and dinner on January 14, 2026, to discuss the Trump administration's antitrust enforcement priorities in tech, healthcare, and life sciences.

The Spring Meeting is the largest gathering of competition, consumer protection, and data privacy profes­sionals globally, with lawyers, academics, economists, enforcers, journalists, and students from around the world.

The Trump administration's DOJ Antitrust Division has introduced a formalized "Expedited Consideration" process for merger reviews, offering a streamlined alternative to full Second Request investigations. This new timing agreement establishes a middle route that focuses initially on the most competitively significant aspects of deals, potentially reducing the months-long compliance burden and multi-million dollar costs traditionally associated with comprehensive merger reviews.

The Federal Circuit recently affirmed a Northern District of West Virginia decision finding no literal or doctrine of equivalents infringement of product-by-process claims requiring a minimum pH level.

The DOJ Antitrust Division’s new Whistleblower Rewards Program could have negative unintended consequences for the leniency program and corporate compliance programs.

On January 29, the Office of the Comptroller of the Currency (OCC) issued a Notice of Proposed Rulemaking for Business Combinations Under the Bank Merger Act.

The Spring Meeting is the largest gathering of competition, consumer protection, and data privacy profes­sionals globally, with lawyers, academics, economists, enforcers, journalists, and students from around the world.

We all know that policymakers are increasingly focused on lowering drug costs. From the Inflation Reductions Act's Medicare price negotiations (aka price controls) to the recent proposals directed...

Earlier this month, I previewed a Federal Circuit oral argument in In re: California Expanded Metal Products Co., No. 2023-1140...

We were so pleased to have the opportunity to address InformaMarkets' 13th Annual Pharma IPR Conference in Mumbai on legal challenges to polymorph patents.

Earlier today the Federal Circuit in Maxell v. Amperex, No. 23-1194, vacated a District Court's indefiniteness determination after distinguishing an indefinite...

A big question when it comes to fair, reasonable and non-discriminatory (FRAND/RAND) defenses for standard essential patents (SEPs) is whether and when a court should issue an injunction.

Tomorrow, the Federal Circuit will hear oral argument in Contour IP Holding LLC v. GoPro, Inc., Case Nos. 2022-1654, -1691...

At least since the Supreme Court's eBay decision in 2006, a vocal contingent has been decrying the erosion of patent rights.

Much like secondary considerations, non-infringing alternatives fit imperfectly within many scheduling orders. The patentee has the burden of proof on damages...

In prior posts for this series, we have discussed areas of law where Commissioners have voiced their dissent and demonstrated a clear divide among the decision-makers.

On July 3, 2024, the World Intellectual Property Organization (WIPO) published a Patent Landscape Report on Generative Artificial Intelligence (GenAI). The report provides a historical and technical overview...

The Spring Meeting is the largest gathering of competition, consumer protection, and data privacy profes­sionals globally, with lawyers, academics, economists, enforcers, journalists, and students from around the world.

As previously reported, the appeal in Fullview v. Polycom, No. 23-1201, involved the question of whether common sense may be relied upon to supply a missing limitation in an obviousness analysis.